ACCESS4ONE

Access4One is a partnership platform. It does not assume discovery alone solves affordability. It coordinates the functions that usually sit apart.

STEPS

 

STEP 1

Prioritize: identify therapies where affordability gains can be achieved quickly and measured clearly.

STEP 2

De-risk: align research, licensing, manufacturing, regulatory, and access partners around a lower-cost pathway.

STEP 3

Launch: support implementation through procurement, provider-system alignment, and patient-access design.

STEP 4

Recycle learning and savings: use evidence and efficiencies to expand the model and support future pilots.

BIOLOGICS BRIDGE

The first phase emphasizes cardiometabolic small molecules because they offer the best early probability of measurable gains within 36 months. Once those capabilities are proven, the same partner-coordination and access-design skills can support biologics and biosimilars.

JOIN US IN BRINGING HEALTH CARE AND KEY MEDICINES TO MILLIONS OF PATIENTS IN NEED

A4ONE is launching and scaling the platform, with opportunities for partners/donors to participate in creating commercially affordable sustainable solutions that have long term impact, for access to medicines.